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ABSTRACT Tropomyosins consist of nearly 100%o a-helix
and assemble into parallel and in-register coiled-coil dimers.
In vitro it has been established that nonmuscle as well as native
muscle tropomyosins can form homodimers. However, a mix-
ture of muscle a and f3 tropomyosin subunits results in the
formation of the thermodynamically more stable a/13 het-
erodimer. Although the assembly preference of the muscle
tropomyosin heterodimer can be understood thermodynami-
cally, the presence of multiple tropomyosin isoforms ex-
pressed in nonmuscle cells points toward a more complex
principle for determining dimer formation. We have investi-
gated the dimerization of rat tropomyosins in living cells by
the use of epitope tagging with a 16-aa sequence of the
influenza hemagglutinin. Employing transfection and immu-
noprecipitation techniques, we have analyzed the dimers
formed by muscle and nonmuscle tropomyosins in rat fibro-
blasts. We demonstrate that the information for homo- versus
heterodimerization is contained within the tropomyosin mol-
ecule itself and that the information for the selectivity is
conferred by the alternatively spliced exons. These results
have important implications for models of the regulation of
cytoskeletal dynamics.
Tropomyosins (TMs) are a family of actin filament-binding
proteins that are among the major components of the thin
filaments of striated and smooth muscle and the microfila-
ments of nonmuscle cells (1). Although TMs are expressed in
all cells, different isoforms of the protein are characteristic of
specific cell types. Isoform diversity of TMs in vertebrate cells
is generated by a combination of four genes, multiple promot-
ers, and alternative splicing mechanisms (2-4). We are just
beginning to understand the relationship of TM isoform
expression and function (5), and although a large number of
TM isoforms have been identified, the specific function of
these isoforms in different cell types remains to be determined.
The TM subunits consist of nearly 100% a-helix, and two
chains assemble into parallel and in-register coiled-coil dimers
(6, 7). TM functions as a dimer and isoform diversity allows a
variety of different dimers to be formed. One of the key
questions in the understanding of TM function is what mech-
anisms are responsible for the regulation of the assembly of
homo- and heterodimers and whether cell type-specific factors
are involved in this process. Rat embryo fibroblasts (REF 52
cell line) express seven nonmuscle TM isoforms simulta-
neously (refs. 3 and 4; W. Guo and D.M.H., unpublished
work): three high molecular weight (HMW) TMs (TM1, TM2,
and TM3) and four low molecular weight (LMW) TMs (TM4,
TM5, TM5a, and TM5b) of 284 and 248 aa, respectively.
Skeletal and smooth muscle a and 1 TM subunits preferen-
tially assemble into the thermodynamically more stable a/P3
heterodimers (8-10). By contrast, studies of TMs from fibro-
blasts demonstrate that these isoforms exist as homodimers
(11, 12), suggesting a more complex principle for determining
the formation and stabilization of a specific and functional
dimer. Because specificity is determined additionally by the
relative thermodynamic stability of all possible protein-
protein interactions, understanding this process requires iden-
tification of the forces that stabilize preferentially the favored
complex as well as forces that destabilize the incorrect one
(13). Several groups have addressed the question of homo-
versus heterodimer formation, using purified muscle (10, 14,
15) or nonmuscle (11, 12) TMs. However, all of these ap-
proaches required either denaturation (10, 14) or chemical
stabilization (11, 12, 16) of the TM chains. Thus, these
approaches might not identify the possible involvement of
cellular factors in the selective formation of TM dimers. This
type of assay also seemed not to be suitable for identifying the
state and composition of the TM dimers prior to the chemical
and thermal treatment. In addition, isoform-specific antibod-
ies are not available for all the isoforms expressed in a single
nonmuscle cell, thereby hindering the ability to recover specific
TMs in order to identify the subunits present in a given dimer.
In the present study we have used living cells as a system to
generate TMs containing the correct set of posttranslational
modifications essential for the correct function ofTM (17-24).
We investigated the dimerization of TMs in cultured cells by
epitope tagging with a 16-aa sequence of influenza hemag-
glutinin (HA-tag) (25, 26) to allow the identification of the
native composition ofTM homo- and heterodimers. We used
immunoprecipitation from extracts of transiently transfected
REF 52 cells at low temperature, where chain exchange is
minimized (14), to analyze the composition of the dimers. We
demonstrate that the information for homo- versus het-
erodimerization is contained within the TM molecule itself
and that the information for the selectivity is conferred by the
alternatively spliced exons.
EXPERIMENTAL PROCEDURES
Construction of Transfection Plasmids. All TM constructs
were cloned in-frame between Xba I and BamHI sites in the
pCGN expression vector (27) with or without the 16-aa
HA-tag sequence. Primers were 5'-ATGGACGCCATCAA-
GAAGAAG-3' for TM1, TM2, TM3, smooth muscle a-TM,
and skeletal muscle a-TM; 5'-ATGGCCGGCCTCAACTCA-
CTG-3' for TM4; and 5'-ATGGCGGGTAGCTCGCTG-3'
for TM5a and TM5b. Each tagged TM therefore carried the
HA-tag sequence at its amino terminus.
Abbreviations: TM, tropomyosin; HMW, high molecular weight;
LMW, low molecular weight; HA, hemagglutinin.
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Immunofluorescence. Rat embryo fibroblast (REF 52) cells
grown to 75% confluence in Dulbecco's modified Eagle's
medium with 10% fetal bovine serum were transfected with 1
,ug of total DNA per construct and 25 gl of Lipofectamine
(GIBCO) per 60-mm dish for 24 hr and prepared for immu-
nofluorescence as described (28). Tagged TMs were visualized
with anti-HA antibody 12CA5 and rhodamine-conjugated goat
anti-mouse secondary antibody (Molecular Probes). Fluores-
cent images were photographed on a Zeiss Axiophot micro-
scope using a x63 oil-immersion lens and Kodak P3200 Tmax
film. The transfection efficiency in REF 52 cells was observed
to be at around 10% with the Lipofectamine method.
Immunoprecipitation. REF 52 cells after 24 hr of transfec-
tion were washed three times with ice-cold phosphate-buffered
saline (pH 7.4) containing 5 mM MgCl2 and 2 mM EGTA.
Proteins for immunoprecipitation were extracted in 200 ,dl of
IP buffer [20 mM imidazole/300 mM KCI/5 mM MgCl2/5%
(vol/vol) glycerol/1% (vol/vol) Triton X-100/1 mM phenyl-
methanesulfonyl fluoride/i mM NaN3/1 mM ATP, pH 7.0]
per 60-mm dish for 60 min on ice. Cellular residue was
removed by centrifugation and the extract was precleared for
60 min with protein A-Sepharose (Pharmacia) in IP buffer.
The supernatant was transferred to a fresh tube washed twice
for 5 min in IP buffer to reduce nonspecific binding. Five
micrograms of 12CA5 antibody was added and the suspension
was incubated on ice for 60 min. After addition of 30 ,ul of
protein A-Sepharose, incubation was continued for another 60
min. The beads were washed three times in IP buffer and once
in phosphate-buffered saline and then prepared for gel elec-
trophoresis.
Electrophoresis and Western Blotting. Analytical SDS/
12.5% PAGE in mini-slab gels and Western blotting onto
nitrocellulose (Hybond, Amersham) were performed as de-
scribed (29). Transferred proteins were visualized with a
horseradish peroxidase-coupled secondary antibody and the
ECL chemiluminescence detection system (Amersham).
Antibodies. Monoclonal anti-TM antibody (clone 311) that
recognizes all the HMW TMs was from Sigma. Monoclonal
anti-HA antibody (clone 12CA5; refs. 25 and 26) was produced
as mouse ascites fluid in Cold Spring Harbor. Monoclonal
anti-TM antibody (clone MP10) that recognizes the low mo-
lecular weight TMs was kindly provided by Mark Pittenger
(Cold Spring Harbor Laboratory).
RESULTS
Cell Transfection. We have used the expression vector
pCGN (Fig. 1A) for the transfection of mammalian cells with
each of the nine rat TM isoforms, which are the products of the
three genes depicted in Fig. 1B. Each TM was expressed either
with or without an amino-terminal 16-aa HA-tag. Transfected
rat embryo fibroblast (REF 52) cells expressed significant
amounts of the tagged TM isoforms, and no premature
chain-termination products were detected by Western blotting
(Fig. 2). The ratio of exogenous TM subunits to the major
endogenous TM subunit (TM1 in REF 52 cells) was deter-
mined to be at about 1:1. This value represents a semiquan-
titative estimate from Western blots of total cell extracts (with
an estimated transfection efficiency of 10%) and is therefore
not equivalent to the situation found in every single cell.
Further, the levels of expression (as determined by immuno-
fluorescence) additionally varied by a factor of -20, and cells
expressing very high amounts of tagged TM contained large
cisternal structures filled with immunoreactive material (data
not shown).
Incorporation of Tagged TM Isoforms into Actin Stress
Fibers. Tagged TMs were incorporated into the actin-
containing stress fibers of REF 52 cells within 24 hr after
transfection. The immunofluorescent patterns obtained with
the 12CAM antibody (Fig. 3) are comparable with those seen
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FIG. 1. (A) Mammalian expression vector pCGN. From left to
right, labeled features include the human cytomegalovirus (CMV)
promoter, the herpes simplex virus (HSV) thymidine kinase (tk) gene
5' untranslated leader and initiation codon, the unique Xba I site
engineered downstream of the initiation codon, the engineered
BamHI site, the rabbit f3-globin gene segment containing splicing and
poly(A)-addition signals, and the simian virus 40 (SV 40) origin of
replication (ori). (B) Intron-exon organization of the rat TM genes
and spliced TM isoforms used for transfection. Nonmuscle cells
express multiple isoforms of 284 aa (TM1, TM2, and TM3) and 248 aa
(TM4, TM5a, and TM5b) simultaneously, whereas muscle cells express
either one (the a isoform in cardiac muscle) or two (both a and ,B
chains in smooth or skeletal muscle) of the HMW type.
with TM-specific antibodies (30). Thus, the tag sequence at the
amino terminus did not interfere with the ability of the TMs
to associate with F-actin bundles. The HA-tagged TMs were
also expressed in and purified from Escherichia coli and were
found to cosediment with F-actin in an in vitro cosedimenta-
tion assay with rabbit skeletal muscle F-actin (data not shown).
This result is consistent with previous studies demonstrating
that wild-type recombinant TM was incorporated into stress
fibers whether it was unacetylated (30, 31) or blocked by an
80-residue amino-terminal fusion (31) and that the patterns of
--
FIG. 2. Western blotting of whole cell extracts with anti-HA
antibody 12CA5 demonstrating the high amounts of tagged TM
isoforms present in transfected REF 52 cells.
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FIG. 3. Immunofluorescence showing that all HA-tagged isoforms localize and integrate into the actin-containing stress fibers of REF 52 cells.
(Bar = 20 JLm.)
incorporated TM were indistinguishable from that of endog-
enous TM (30) or isolated chicken pectoral muscle TM (31).
Dimer Formation. The transient expression of HA-tagged
or untagged exogenous TM isoforms in REF 52 cells allows the
formation of a variety of dimers in addition to the dimers
present in the untransfected cells (Fig. 4A). Besides the native
homo- or heterodimers containing the endogenous TM chains
(I), hybrid dimers containing either one (II) or two (III) tagged
exogenous TM chains are possible. In addition, in double
transfections where one tagged isoform and one untagged
isoform are introduced into cells simultaneously, the forma-
tion of "native hybrids" containing two untagged chains, one
endogenous and one exogenous, are possible. The differences
in electrophoretic mobility due to the presence of the 16-aa tag
allow the identification of both homodimers and heterodimers
by SDS/12.5% PAGE. When extracts from metabolically
35S-labeled transfected REF 52 cells were separated in SDS/
12.5% polyacrylamide gels and autoradiographed, the expres-
sion of the tagged TM chains in these cells 24 hr after
transfection was seen to be comparable to that of the endog-
enous TMs. Immunoprecipitations from these cell extracts
further revealed that the tagged TMs were precipitated in
equal amounts by the anti-HA antibody and that actin con-
tamination was negligible (data not shown).
Western blot analysis of the immunoprecipitated tag-
containing dimers demonstrated the preference of the 284-aa
HMW nonmuscle isoforms TM1, TM2, and TM3 to form
homodimers (Fig. 4B). REF 52 cells express the three HMW
TM isoforms in different amounts (TM1 > TM2 >> TM3). To
eliminate problems due to differential amounts of exogenous
and endogenous TMs present in the extracts, cotransfections
were performed with the same expression vector introducing
the same TM subunit both tagged and untagged into the cells.
Cotransfections of tagged TM constructs in parallel with
untagged TMs did not alter the homodimer preference of the
HMW nonmuscle isoforms (Fig. 4C).
Since fibroblast TM2 differs from smooth muscle a-TM or
skeletal muscle a-TM by the use of exons 2a/2b or 9a/9d,
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FIG. 4. (A) Contribution of the different possible dimers to the
bands analyzed in SDS/polyacrylamide gels (see text). Open bars
symbolize the TM chains; black boxes indicate the presence or absence
of the HA-tag sequence. (B) Western blot analysis of anti-HA
(12CA5) immunoprecipitates probed with a monoclonal antibody
recognizing all HMW TMs (clone 311; Sigma). Single transfections of
REF 52 cells with each of the nonmuscle HMWTM variants resulted
in the precipitation of predominantly homodimers of the respective
TM subunits. The presence of the 16-aa HA-tag increases the apparent
molecular mass of the monomer chain by -2 kDa, allowing the
identification of both tagged (upper band) and untagged (lower band)
TMs according to their mobility in SDS/12.5% polyacrylamide gels.
Two strongly reacting bands represent the reaction of the heavy (Ab
hc) and light (Ab lc) chains of the added 12CA5 antibody with the goat
anti-mouse secondary antibody. Area between arrows indicates posi-
tion ofTMs. When an extract of untransfected cells was used (control),
no TMs were identified in the immunoprecipitate. (C) Double trans-
fections using both one tagged and one untagged HMW isoform
resulted in the precipitation of homodimers.
respectively (see Fig. IB), it was possible that these alterna-
tively spliced exons were critical for the selective formation of
homo- versus heterodimers. When tagged smooth muscle
a-TM or skeletal muscle a-TM isoforms were cotransfected
with untagged HMW nonmuscle TM isoforms, the formation
of heterodimer was predominant (Fig. 5 A and B). Similarly,
skeletal muscle (3-TM formed heterodimers with TM1, TM2,
xxx x x xxxx xxxxxx
xclxx
}~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~1
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and TM3 (Fig. 5 A and B). Thus, the muscle isoforms were
capable of shifting the dimer equilibrium in the direction of the
heterodimer. The selectivity of the dimer formation was
further indicated by the results obtained with combinations of
HMW and LMW TM isoforms. Tagged smooth muscle a-TM,
skeletal muscle }3-TM, or nonmuscle TM2 failed to form stable
heterodimers with cotransfected LMW nonmuscle yariant
TM4, TM5a, or TM5b (Fig. SC).
DISCUSSION
Coiled coils are found as stabilizing motifs in many different
types of dimeric proteins. In the case of the basic region-
leucine zipper (bZIP) family of transcription factors, Lumb
and Kim (32) demonstrated that the dimerization into parallel
coiled-coil dimers was controlled by the leucine zipper se-
quence. Similarly, O'Shea et al. (13) identified 8 residues in the
35-aa leucine zipper region of the oncoproteins Fos and Jun as
the essential determinants for their heterodimerization into
parallel, two-stranded coiled coils and demonstrated that the
driving force for preferential heterodimer formation was the
destabilization of the Fos homodimer. In addition, neurotro-
phins have been shown to be biologically active as nonco-
valently linked homodimers. Recently, Heymach and Shooter
(33) have used a technique similar to the one applied in this
work to show that three members of the neurotrophin family
(nerve growth factor, brain-derived neurotrophic factor, and
neurotrophin 3) were able to form heterodimers upon forced
expression following transfection of cells. Our results demon-
strate that amino- and carboxyl-terminal regions, as well as
internal regions, contribute to the coiled-coil interactions of
the TM subunits.
There is general agreement that the a-helical TM molecule
unfolds and dissociates in parallel during a heating experiment,
indicating regions of varying stability or many states of par-
tially unfolded molecules. The unfolding of heterodimers is
expected to be even more complex than that of homodimers,
since not only domains or states of heterodimers are involved,
but homodimer domains (or states) also contribute to the
equilibrium state (34). In a CD study of Rana esculenta a/(
TM, two major helix-coil transitions were observed which
have been interpreted as the unfolding of independent do-
mains (34). Ishii et al. (35, 36) have demonstrated that recom-
binant TMs carrying an amino-terminal fusion peptide are still
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FIG. 5. (A and B) Cotransfections using HA-tagged muscle isoforms in combination with untagged HMW nonmuscle isoforms resulted in the
predominant formation of stable heterodimers. Western blots of anti-HA immunoprecipitates were probed with anti-HA antibody 12CA5 (A) and
anti-TM antibody 311 (B). (C) When either muscle TMs or a HMW nonmuscle TM (TM2) was cotransfected with LMW nonmuscle TMs, however,
no stable dimers were precipitated. Western blot probed with a mixture of antibodies 12CA5 and MP10 (gift of Mark Pittenger; recognizes low
molecular weight TMs). Area between arrows indicates position of TMs.
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close together for local unfolding while they are separated for
global unfolding. The conformation of the local unfolded
region and the mechanism of the local unfolding of TM
remained unsolved, however.
Whereas rat muscle cells express only one (cardiac) or two
(smooth and skeletal) isoforms of TM, up to seven different
TMs are present in a single rat fibroblast (refs. 4 and 30;
W. Guo and D.M.H., unpublished work). We have shown that
the presence of the amino-terminally tagged transfected mus-
cle isoforms in a nonmuscle cell leads to the formation of
heterodimers between endogenous and exogenous HMW non-
muscle TMs. Muscle-specific factors cannot be involved in the
process of the formation (or stabilization) of heterodimers
since this process is taking place in a cultured nonmuscle cell.
Nonmuscle-specific factors were also not effective in main-
taining the homodimeric state of the endogenous nonmuscle
TMs in the presence of the transfected muscle isoforms.
Different TM isoforms differ in binding to troponin T, the
formation of head-to-tail overlaps, and their affinity for F-
actin (reviewed in refs. 3 and 4). A relationship between
alternatively spliced exons and functional domains in TMs was
found by investigating the influence of exons 2a/b and 9a/d of
the smooth and striated a-TMs (5). Although the presence of
exon 9a was correlated with Ca2+-insensitive binding to troponin
and the presence of exon 2a was correlated with changes in
actin affinity, the individual exons were not recognizable as
individual structural domains (5). Expression of chimeric TMs
in fibroblasts recently indicated that a coordination between
the amino- and carboxyl-terminal regions is required for
normal TM function (37). Our data support this latter assump-
tion and suggest that coordination between several domains in
TMs is responsible for the formation of functionally relevant
TM dimers. Exons 3-5, 7, and 8 are common to all TMs and
appear from our studies to be insufficient to warrant stable
dimerization per se, since stable heterodimers between LMW
and HMW TMs were not observed under our assay conditions.
Whether or not changes in the sequences of these conserved
domains could lead to perturbation of the dimeric interactions
of TM subunits is unknown. Additionally, it will be interesting
to determine the influence of exon lb (used in the 248-aa
subunits of TM4, TM5, TM5a, and TM5b) on the dimerization
properties of the LMW isoforms.
The functional significance of expressing a multitude of TM
isoforms in nonmuscle cells and maintaining them as ho-
modimers remains to be determined. The higher actin-binding
ability of strongly head-to-tail overlapping heterodimers of
smooth muscle a and ,B TM subunits in chicken gizzard might
reflect the necessity to maintain stable association with the
muscle thin filament throughout the entire length of the actin
filament. For chicken gizzard TM, the heterodimer exhibits a
greater ability to bind cooperatively to F-actin, due to its
stronger head-to-tail overlap as compared with the a/a and
f3/j3 homodimers. It has also been suggested that the TM
heterodimers represent a more flexible structure than their
homodimeric counterparts (38). A higher end-to-end associ-
ation of TM heterodimers in smooth muscle cells could lead to
the formation of elongated TM polymers, which could reflect
the requirement for a higher degree of flexibility to accom-
modate the structural changes in the F-actin filament during
contraction and relaxation cycles (38). In contrast, a reduced
ability of the homodimers to associate head-to-tail could be a
necessary determinant for the more dynamic regulation of the
actin cytoskeleton in nonmuscle cells.
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